SSA
DMTK

Schonfeld Strategic Advisors’s DermTech, Inc. Common Stock DMTK Stock Holding History

Schonfeld Strategic Advisors’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-21,600
Closed -$38.2K – 2800
2022
Q4 		$38.2K Buy
+21,600
New +$57.5K ﹤0.01% 2280
2022
Q3 		– Sell
-16,572
Closed -$92K – 3241
2022
Q2 		$92K Buy
+16,572
New +$136K ﹤0.01% 2161

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
EP
EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

Schonfeld Strategic Advisors's DMTK Position: Q1 2023 in Review

Schonfeld Strategic Advisors sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2023, closing a stake of 21,600 shares — an estimated $38.2K sold.

Schonfeld Strategic Advisors first reported a position in DMTK in Q2 2022 and held it in 2 quarters. The position peaked at $92K in Q2 2022. 99 funds tracked by Wall St. Rank hold DMTK as of Q1 2023.

  • Schonfeld Strategic Advisors reported no remaining DermTech, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 21,600 DermTech, Inc. Common Stock shares in Q1 2023, an estimated $38.2K.
  • Schonfeld Strategic Advisors first reported a position in DermTech, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's DermTech, Inc. Common Stock position peaked at $92K in Q2 2022.
  • 99 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.